Literature DB >> 2021346

Complications of percutaneous intra-aortic balloon pump use in patients with peripheral vascular disease.

K H Kvilekval1, R A Mason, G B Newton, C E Anagnostopoulos, S C Vlay, F Giron.   

Abstract

Percutaneous intra-aortic balloon pump use may carry an increased risk for patients with peripheral vascular disease. To determine the incidence and types of associated complications, the medical records of 144 patients who underwent a total of 153 percutaneous intra-aortic balloon pump insertions were reviewed. Patients were divided into two groups. Group 1 was composed of 20 patients with a history of peripheral vascular disease. Group 2 was composed of 124 patients without such history; they underwent a total of 133 insertions. Nineteen major complications (12%) occurred, 12 in group 1 (60% of 20 insertions) and seven in group 2 (5% of 133 insertions). Major complications were further classified by their nature: embolic, occlusive, and technical. All three types of complications occurred more frequently in group 1. Embolic complications occurred more frequently in patients with aneurysms and proved the most lethal, with two of six deaths in group 1 resulting from this complication.

Entities:  

Mesh:

Year:  1991        PMID: 2021346     DOI: 10.1001/archsurg.1991.01410290099019

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Acute aortic thrombosis after intra-aortic balloon pumping.

Authors:  Y Sakakibara; A Sasaki; H Nakata; M Osaka; Y Hiramatsu; T Mitsui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-02

2.  Thrombosis of the abdominal aorta. A rare complication of the intraaortic balloon pumping device.

Authors:  E Leude; A Vaillant; J Nazet; F Collart; E Rosset; C Malmejac
Journal:  Tex Heart Inst J       Date:  1995

Review 3.  Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump.

Authors:  Haralabos Parissis; Alan Soo; Bassel Al-Alao
Journal:  J Cardiothorac Surg       Date:  2011-11-02       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.